SCHEMBL1316514

SCHEMBL1316514

N#Cc1ccc(-c2ccccc2)cc1NC(=O)c1cncc(-c2ccccc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B2 P19099 4/20 0.52
▸ CYP11B1 P15538 3/20 0.52
▸ HDAC1 Q13547 5/20 0.52
▸ SCN10A Q9Y5Y9 2/20 0.52
▸ KCNH2 Q12809 1/20 0.52
▸ HDAC2 Q92769 4/20 0.51
▸ FABP5 Q01469 2/20 0.51
▸ HDAC3 O15379 2/20 0.51
▸ FABP7 O15540 1/20 0.51
▸ FABP3 P05413 1/20 0.51
▸ XDH P47989 1/20 0.49
▸ KAT6A Q92794 1/20 0.47
▸ SCN2A Q99250 1/20 0.46
▸ ABCB1 P08183 1/20 0.46
▸ CCNC P24863 2/20 0.45
▸ CDK8 P49336 2/20 0.45
▸ GAK O14976 1/20 0.44
▸ STK16 O75716 1/20 0.44
▸ PIM1 P11309 1/20 0.44
▸ AXL P30530 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1315497 0.90 MEN1 (0.51) CYP11B2CYP11B1SCN10AKCNH2XDH
SCHEMBL1315751 0.81 ACLY (0.64) HDAC1HDAC2HDAC3XDHKAT6A
SCHEMBL31243011 0.79 CYP11B2 (0.52) CYP11B2CYP11B1SCN10AKCNH2XDH
SCHEMBL6833755 0.78 KCNH2 (0.55) HDAC1SCN10AKCNH2XDHKAT6A
SCHEMBL12118152 0.77 ACLY (0.59) HDAC1HDAC2HDAC3XDHABCB1
SCHEMBL27847091 0.77 HDAC1 (0.59) HDAC1SCN10AHDAC2HDAC3KAT6A
SCHEMBL12118131 0.76 ACLY (0.58) HDAC1SCN10AKCNH2HDAC2HDAC3
SCHEMBL12118188 0.76 HDAC1 (0.62) HDAC1KCNH2HDAC2HDAC3ABCB1
SCHEMBL1316860 0.76 ACLY (0.58) HDAC1HDAC2HDAC3XDHABCB1
SCHEMBL13758180 0.76 HDAC1 (0.63) HDAC1HDAC2FABP5HDAC3FABP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 — — US disclosed
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 — — US disclosed
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 — — US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 — — US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 — — US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 — — US disclosed
EP-2385036-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF Toyama Chemical Co., Ltd. (JP) 2011-11-09 — — EP disclosed
WO-2010087430-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF 富山化学工業株式会社 (JP) 2010-08-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF COL14A1, COL2A1, COL1A1 CYP11B2 833/4885CYP11B1 739/4885HDAC1 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback